Russell Investments Group Ltd. boosted its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 11.8% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 27,619 shares of the company’s stock after buying an additional 2,926 shares during the period. Russell Investments Group Ltd.’s holdings in USANA Health Sciences were worth $1,591,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently bought and sold shares of the stock. Janney Montgomery Scott LLC boosted its position in USANA Health Sciences by 37.7% in the first quarter. Janney Montgomery Scott LLC now owns 6,619 shares of the company’s stock valued at $381,000 after buying an additional 1,813 shares in the last quarter. Quotient Investors LLC purchased a new position in USANA Health Sciences during the first quarter valued at about $605,000. Teachers Advisors LLC boosted its position in USANA Health Sciences by 137.7% in the fourth quarter. Teachers Advisors LLC now owns 217,677 shares of the company’s stock valued at $13,322,000 after buying an additional 126,090 shares in the last quarter. USA Financial Portformulas Corp boosted its position in USANA Health Sciences by 130.8% in the fourth quarter. USA Financial Portformulas Corp now owns 17,969 shares of the company’s stock valued at $1,100,000 after buying an additional 10,185 shares in the last quarter. Finally, Norges Bank purchased a new position in USANA Health Sciences during the fourth quarter valued at about $6,855,000. Hedge funds and other institutional investors own 44.26% of the company’s stock.
Shares of USANA Health Sciences, Inc. (NYSE:USNA) opened at 65.00 on Tuesday. The company has a 50-day moving average of $63.85 and a 200 day moving average of $60.63. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of 16.41 and a beta of 1.10. USANA Health Sciences, Inc. has a one year low of $52.55 and a one year high of $75.00.
USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, May 2nd. The company reported $0.91 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.92 by $0.01. USANA Health Sciences had a return on equity of 31.84% and a net margin of 9.71%. The company had revenue of $255.32 million for the quarter. On average, equities analysts forecast that USANA Health Sciences, Inc. will post $3.95 earnings per share for the current fiscal year.
WARNING: This piece was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/2654223/usana-health-sciences-inc-usna-shares-bought-by-russell-investments-group-ltd.html.
Several equities analysts recently issued reports on the stock. BidaskClub upgraded shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Tuesday, June 13th. Pivotal Research upgraded shares of USANA Health Sciences from a “hold” rating to a “buy” rating and boosted their target price for the company from $55.00 to $75.00 in a research note on Wednesday, May 3rd. Finally, Zacks Investment Research upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Wednesday, April 12th.
In other USANA Health Sciences news, Director Myron W. Wentz sold 40,000 shares of the firm’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $64.99, for a total value of $2,599,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Paul A. Jones sold 9,851 shares of the firm’s stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $64.50, for a total value of $635,389.50. Following the completion of the sale, the insider now directly owns 6,020 shares of the company’s stock, valued at approximately $388,290. The disclosure for this sale can be found here. In the last three months, insiders sold 174,735 shares of company stock valued at $10,349,724. 53.20% of the stock is owned by corporate insiders.
About USANA Health Sciences
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.